The use of cladribine in neurosarcoidosis: A report of two cases

[1]  A. Prasse,et al.  The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[2]  A. Oterino,et al.  Anti-TNF-α therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review. , 2014, Clinical and experimental rheumatology.

[3]  M. Hagiwara,et al.  Neurosarcoidosis: Presentations and Management , 2010, The neurologist.

[4]  M. Kupersmith,et al.  Treatment of refractory neurosarcoidosis with cladribine. , 2004, The New England journal of medicine.

[5]  J. Mazur,et al.  Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. , 2003, Chest.

[6]  J. Broderick,et al.  Diagnosis and management of neurological sarcoidosis. , 1997, Archives of internal medicine.

[7]  A. Bonakdarpour,et al.  Case report 24 , 1977, Skeletal Radiology.

[8]  R. Schreiber.  Case report 13 , 1976, Skeletal Radiology.

[9]  T. Robak,et al.  Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders. , 2006, Reviews on recent clinical trials.